![LYCOPUS 1 [hp_X]/100mL; 1 [hp_X]/100mL; 6 [hp_X]/100mL; 6 [hp_X]/100mL; 8 [hp_X]/100mL; 8 [hp_X]/100m Liquid, 50 mL — NDC 60986-1030-03 package photo](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f60712dc-d6ba-4773-87c5-2f4207c72a94&name=N19_60986-1030-4.jpg)
LYCOPUS 1 [hp_X]/100mL; 1 [hp_X]/100mL; 6 [hp_X]/100mL; 6 [hp_X]/100mL; 8 [hp_X]/100mL; 8 [hp_X]/100m Liquid, 50 mL
by Marco Pharma International LLC. · 50 mL in 1 BOTTLE, GLASS (60986-1030-3)
NDC 60986-1030-03
🏷️ FDA NDC (as labeled)
60986-1030-3
billing pads the package segment with a zero
This package
Contains50 mL
Pack sizes2 compare ↓
Also comes in:
100 ml 60986-1030-04
OTC
Discontinued
Non-controlled
⚠ Discontinued by firm
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Excluded from the active FDA NDC Directory.
The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
🆔 Identity & classification
FDA NDC (as labeled)
60986-1030-3
Product NDC
60986-1030
11-digit billing NDC
60986103003
UNII
TWH5125Q6F, 1PIP394IID, 59150S2EOG, 42QO5P0NLM, 91D9GV0Z28, HF539G9L3Q
SPL Set ID
f60712dc-d6ba-4773-87c5-2f4207c72a94
Established class (EPC)
Blood Coagulation Factor; Calculi Dissolution Agent; Cations; Inhi
Physiologic effect
Increased Coagulation Factor Activity; Increased Large Intestinal Motility; Inhibition Large Intestine Fluid/Electrolyte Absorption
Chemical class
Calcium; Divalent
DEA schedule
Non-controlled
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing status
Discontinued
FDA listing status
Discontinued by firm
Marketing start
1992-03-01
Route
ORAL
Dosage form
LIQUID
Substance
LYCOPUS VIRGINICUS; SPONGIA OFFICINALIS SKELETON, ROASTED; LOPHOPHYTUM LEANDRII; QUININE ARSENITE; TRIBASIC CALCIUM PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE
Why two NDCs?
The FDA registers this code as 60986-1030-3 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 60986-1030-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerMarco Pharma International LLC.
Labeler code60986
First marketedMar 1992
Product typeHuman Otc Drug
Portfolio13 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
🧪 What is this product?
This is an unapproved homeopathic liquid taken by mouth that contains multiple plant and mineral substances, including extract from bugleweed (Lycopus virginicus), roasted sponge skeleton, calcium and magnesium phosphates, and other traditional homeopathic ingredients. In homeopathic practice, these substances are typically used to support respiratory and glandular function. Homeopathic products are marketed based on traditional use and have not been evaluated by the FDA for safety or effectiveness.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about LYCOPUS VIRGINICUS, SPONGIA TOSTA, LOPHOPHYTUM LEANDRII, CHININUM ARSENICOSUM, CALCAREA PHOSPHORICA, MAGNESIA PHOSPHORICA?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 3K9958V90M
A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
2 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesEthyl Alcohol (53% by vol.) and Water
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
100 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Lycopus 1 [hp_X]/100mL; 1 [hp_X]/100mL; 6 [hp_X]/100mL; 6 [hp_X]/100mL; 8 [hp_X]/100mL; 8 [hp_X]/100mthis 60986-1030-03 | Marco | 50 ml | — | — | Discontinued | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
1992
On the market since
Mar 1992
📍
2026
Currently FDA-listed
34 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 60986-1030-03 You're viewing this | 50 mL in 1 BOTTLE, GLASS (60986-1030-3) | 2018-02-28 | Discontinued by firm |
| 60986-1030-04 | 100 mL in 1 PACKAGE (60986-1030-4) | 2018-02-28 | Active |
You're viewing the smallest of 2 pack sizes for this product.
Pack size FAQ
What quantity is in NDC 60986-1030-03?
NDC 60986-1030-03 contains 50 mL — 50 ml in 1 bottle, glass.
What is the difference between NDC 60986-1030-03 and NDC 60986-1030-04?
Both are LYCOPUS 1 [hp_X]/100mL; 1 [hp_X]/100mL; 6 [hp_X]/100mL; 6 [hp_X]/100mL; 8 [hp_X]/100mL; 8 [hp_X]/100m Liquid — the drug itself is identical. NDC 60986-1030-03 is the 50 mL package, while NDC 60986-1030-04 is the 100 ml package.
What NDC number is used to bill for this package of LYCOPUS 1 [hp_X]/100mL; 1 [hp_X]/100mL; 6 [hp_X]/100mL; 6 [hp_X]/100mL; 8 [hp_X]/100mL; 8 [hp_X]/100m Liquid?
Bill NDC 60986-1030-03 — the 11-digit billing format is 60986103003. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
Homeopathic listing
No longer marketed (per FDA listing data)
About homeopathic listings
LYCOPUS 1 [hp_X]/100mL; 1 [hp_X]/100mL; 6 [hp_X]/100mL; 6 [hp_X]/100mL; 8 [hp_X]/100mL; 8 [hp_X]/100m LIQUID is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 60986-1030-3, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 60986-1030-03, written without dashes as 60986103003. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 60986-1030-03, the first segment (60986) is the labeler code FDA assigned to Marco Pharma International LLC.; the middle segment (1030) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (03) identifies this exact package size and type. Together they name one specific package of one specific product.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 100 ml (60986-1030-04). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Marco Pharma International LLC. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Dosage Adults take 5 drops on the tongue or in 1 tablespoon water 3 times daily, increasing by one drop daily until reaction level is reached. Maxixum amount: 20 drops three times daily. Children receive 1/2 or less of the adult amount.
⏱️ Dosage and Administration ▾
(Read Suggested Use Section)
⚠️ Warnings ▾
Warnings If pregnant or breast-feeding, consult a health professional before use.
🧪 Active Ingredient ▾
Active Ingredients Bugleweed 1X HPUS Sponge 1X HPUS Stone Blossom 6X HPUS Quinine 6X HPUS Tribasic calcium phosphate 8X HPUS Magnesium hydrogen phosphate 8X HPUS The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates. Purpose For thyroid conditions: hyperthyroid with palpitations. Keep out of reach of children.
Dosage Adults take 5 drops on the tongue or in 1 tablespoon water 3 times daily, increasing by one drop daily until reaction level is reached. Maxixum amount: 20 drops three times daily. Children receive 1/2 or less of the adult amount.
Warnings If pregnant or breast-feeding, consult a health professional before use. (Read Suggested Use Section) Inactive Ingredients Ethyl Alcohol (53% by vol.) and Water
🧪 Inactive Ingredients ▾
Inactive Ingredients Ethyl Alcohol (53% by vol.) and Water
🎯 Purpose ▾
Purpose For thyroid conditions: hyperthyroid with palpitations.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.